| primary aneurysmal bone cysts are mesenchymal neoplasms exhibiting USP6 and/or CDH11 oncogenic rearrangements | neoplasm, |
| The Tre2 oncoprotein, implicated in Ewing s sarcoma, interacts with two components of the cytoskeleton. | sarcoma, |
| TRE17/ubiquitin-specific protease 6 (USP6) oncogene translocated in aneurysmal bone cyst blocks osteoblastic maturation via an autocrine mechanism involving bone morphogenetic protein dysregulation. | None |
| Atypical mechanism of NF-kappaB activation by TRE17/ubiquitin-specific protease 6 (USP6) oncogene and its requirement in tumorigenesis. | None |
| The oncogenic TBC domain protein USP6/TRE17 regulates cell migration and cytokinesis. | None |
| The TRE17/USP6 oncogene: a riddle wrapped in a mystery inside an enigma. | None |
| Human TRE17 oncogene is generated from a family of homologous polymorphic sequences by single-base changes. | None |
| The normal copy of the G0S19-3-associated, CpG island-containing, upstream sequence is downstream of G0S19-2/MIP1alpha in association with a TRE17 oncogene. | None |
| The Tre2 (USP6) oncogene is a hominoid-specific gene. | None |
| The TRE17 oncogene encodes a component of a novel effector pathway for Rho GTPases Cdc42 and Rac1 and stimulates actin remodeling. | None |
| Expression in a RabGAP yeast mutant of two human homologues, one of which is an oncogene. | None |
| A novel transcriptional unit of the tre oncogene widely expressed in human cancer cells. | None |
| At least two regions of the oncoprotein Tre2 are involved in its lack of GAP activity. | None |
| Tre2 oncogene seems to encode a nonfunctional Rab GAP. As regions flanking the TBC domain may be crucial for catalytic activity | None |
| Evidence for involvement of TRE-2 (USP6) oncogene, low-copy repeat and acrocentric heterochromatin in two families with chromosomal translocations. | None |
| Mutational analysis of the TRE2 oncogene encoding an inactive RabGAP. | None |
| A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | None |
| TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappaB. | None |
| TRE17/ubiquitin-specific protease 6 (USP6) oncogene translocated in aneurysmal bone cyst blocks osteoblastic maturation via an autocrine mechanism involving bone morphogenetic protein dysregulation. | None |
| the oncogenic potential of USP6 is linked to its ability to integrate cell migration and cytokinesis by regulating Arf6/ACAP1. | None |